These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 19808298)

  • 61. Biomarkers of Systemic Inflammation and Risk of Incident Hearing Loss.
    Gupta S; Curhan SG; Curhan GC
    Ear Hear; 2019; 40(4):981-989. PubMed ID: 30399011
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years.
    Nicola PJ; Maradit-Kremers H; Roger VL; Jacobsen SJ; Crowson CS; Ballman KV; Gabriel SE
    Arthritis Rheum; 2005 Feb; 52(2):412-20. PubMed ID: 15692992
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Increased heart failure risk in normal-weight people with metabolic syndrome compared with metabolically healthy obese individuals.
    Voulgari C; Tentolouris N; Dilaveris P; Tousoulis D; Katsilambros N; Stefanadis C
    J Am Coll Cardiol; 2011 Sep; 58(13):1343-50. PubMed ID: 21920263
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Sleep Timing May Predict Congestive Heart Failure: A Community-Based Cohort Study.
    Yan B; Li R; Li J; Jin X; Gao F; Gao Y; Ren J; Zhang J; Wang X; Wang G
    J Am Heart Assoc; 2021 Mar; 10(6):e018385. PubMed ID: 33666090
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Hormone replacement therapy and the risk of incident congestive heart failure: the Cardiovascular Health Study.
    Rea TD; Psaty BM; Heckbert SR; Cushman M; Meilahn E; Olson JL; Lemaitre RN; Smith NL; Sotoodehnia N; Chaves PH
    J Womens Health (Larchmt); 2003 May; 12(4):341-50. PubMed ID: 12804341
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effects of periodontal treatment on inflammation and oxidative stress markers in patients with metabolic syndrome.
    Torumtay G; Kırzıoğlu FY; Öztürk Tonguç M; Kale B; Calapoğlu M; Orhan H
    J Periodontal Res; 2016 Aug; 51(4):489-98. PubMed ID: 26547140
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Chronic inflammation and risk of lung cancer in older adults in the health, aging and body composition cohort study.
    Demb J; Wei EK; Izano M; Kritchevsky S; Swede H; Newman AB; Shlipak M; Akinyemiju T; Gregorich S; Braithwaite D
    J Geriatr Oncol; 2019 Mar; 10(2):265-271. PubMed ID: 30078713
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Inflammation and ventricular-vascular coupling in hypertensive patients with metabolic syndrome.
    Zanoli L; Di Pino A; Terranova V; Di Marca S; Pisano M; Di Quattro R; Ferrara V; Scicali R; Rabuazzo AM; Fatuzzo P; Castellino P; Piro S; Purrello F; Malatino L
    Nutr Metab Cardiovasc Dis; 2018 Dec; 28(12):1222-1229. PubMed ID: 30348591
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Additive value of interleukin-6 and C-reactive protein in risk prediction for all-cause and cardiovascular mortality among a representative adult cohort in Taiwan.
    Lin YH; Glei D; Weinstein M; Wu SI; Chien KL
    J Formos Med Assoc; 2017 Dec; 116(12):982-992. PubMed ID: 28292623
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Insulin resistance and risk of congestive heart failure.
    Ingelsson E; Sundström J; Arnlöv J; Zethelius B; Lind L
    JAMA; 2005 Jul; 294(3):334-41. PubMed ID: 16030278
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Inflammation biomarkers and mortality prediction in patients with type 2 diabetes (ZODIAC-27).
    Landman GW; Kleefstra N; Groenier KH; Bakker SJ; Groeneveld GH; Bilo HJ; van Hateren KJ
    Atherosclerosis; 2016 Jul; 250():46-51. PubMed ID: 27179179
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The associations of metabolic syndrome with incident hypertension, type 2 diabetes mellitus and chronic kidney disease: a cohort study.
    Ding C; Yang Z; Wang S; Sun F; Zhan S
    Endocrine; 2018 May; 60(2):282-291. PubMed ID: 29492904
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Depression, inflammation, and incident cardiovascular disease in women with suspected coronary ischemia: the National Heart, Lung, and Blood Institute-sponsored WISE study.
    Vaccarino V; Johnson BD; Sheps DS; Reis SE; Kelsey SF; Bittner V; Rutledge T; Shaw LJ; Sopko G; Bairey Merz CN;
    J Am Coll Cardiol; 2007 Nov; 50(21):2044-50. PubMed ID: 18021871
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Association of Oxytocin with Glucose Intolerance and Inflammation Biomarkers in Metabolic Syndrome Patients with and without Prediabetes.
    Akour A; Kasabri V; Bulatova N; Al Muhaissen S; Naffa R; Fahmawi H; Momani M; Zayed A; Bustanji Y
    Rev Diabet Stud; 2018; 14(4):364-371. PubMed ID: 29590229
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Biomarkers of inflammation and risk of cardiovascular events in anticoagulated patients with atrial fibrillation.
    Hijazi Z; Aulin J; Andersson U; Alexander JH; Gersh B; Granger CB; Hanna M; Horowitz J; Hylek EM; Lopes RD; Siegbahn A; Wallentin L;
    Heart; 2016 Apr; 102(7):508-17. PubMed ID: 26839066
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Prediction of mortality risk in the elderly.
    Störk S; Feelders RA; van den Beld AW; Steyerberg EW; Savelkoul HF; Lamberts SW; Grobbee DE; Bots ML
    Am J Med; 2006 Jun; 119(6):519-25. PubMed ID: 16750966
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The association between circulating inflammatory markers and metabolic syndrome in Korean rural adults.
    Ryu SY; Kim KS; Park J; Kang MG; Han MA
    J Prev Med Public Health; 2008 Nov; 41(6):413-8. PubMed ID: 19037171
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Total and differential white blood cell counts, inflammatory markers, adipokines, and incident metabolic syndrome in phase 1 of the clinical antipsychotic trials of intervention effectiveness study.
    Kelly CW; McEvoy JP; Miller BJ
    Schizophr Res; 2019 Jul; 209():193-197. PubMed ID: 31118157
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Serum high-sensitivity C-reactive protein as a biomarker in patients with metabolic syndrome: evidence-based study with 7284 subjects.
    Mirhafez SR; Ebrahimi M; Saberi Karimian M; Avan A; Tayefi M; Heidari-Bakavoli A; Parizadeh MR; Moohebati M; Azarpazhooh MR; Esmaily H; Nematy M; Safarian M; Ferns GA; Ghayour-Mobarhan M
    Eur J Clin Nutr; 2016 Nov; 70(11):1298-1304. PubMed ID: 27460263
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Laboratory indicators of pathological changes in patients with chronic heart failure with metabolic syndrome.
    Roytman AP; Sedova NA; Godkov MA
    Klin Lab Diagn; 2021 Mar; 66(2):75-79. PubMed ID: 33734639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.